CareDx, Inc (CDNA) vs Edgewise Therapeutics, Inc. (EWTX)
A side-by-side comparison of CareDx, Inc and Edgewise Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDNA
CareDx, Inc
$69.85HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
EWTX
Edgewise Therapeutics, Inc.
$40.30HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CDNA vs EWTX
growth of $100 · dividends reinvested · last 6yCDNA +10.1% (+1.6%/yr)EWTX +34.3% (+5.0%/yr)EWTX compounded faster over this window
CDNA EWTX
CDNA vs EWTX: by the numbers
- •EWTX is the larger company ($4.34B vs $3.61B market cap).
- •CDNA is profitable (24.23% net margin) while EWTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CDNA | EWTX |
|---|---|---|
| P/E ratio | 33.72 | N/A |
| Forward P/E | 58.32 | N/A |
| P/S ratio | 7.89 | N/A |
| P/B ratio | 8.49 | 9.68 |
| EV / EBITDA | 209.49 | N/A |
| FCF yield | 2.35% | N/A |
Profitability
| Metric | CDNA | EWTX |
|---|---|---|
| Gross margin | 70.58% | 0.00% |
| Operating margin | -0.92% | 0.00% |
| Net margin | 24.23% | 0.00% |
| ROE | 26.08% | -44.02% |
| ROIC | -0.93% | -48.57% |
Growth (annualized)
| Metric | CDNA | EWTX |
|---|---|---|
| Revenue CAGR (5Y) | 12.56% | N/A |
| Total return CAGR (5Y) | 1.33% | 16.95% |
Frequently asked
- Is CDNA or EWTX more profitable?
- CDNA runs the higher net margin — CDNA at 24.23% versus EWTX at 0.00%.
- How have CDNA and EWTX total returns compared?
- Over the past 5 years, CDNA delivered 1.33% and EWTX delivered 16.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CareDx P/E ratioCareDx ROEEdgewise Therapeutics ROECareDx operating marginEdgewise Therapeutics operating marginCareDx revenue growthEdgewise Therapeutics revenue growthCareDx free cash flowEdgewise Therapeutics free cash flow
CareDx & Edgewise Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.